רÀûÃû³Æ£ºÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°ÖõÄÖÆ×÷·½·¨
¼¼ÊõÁìÓò£º
±¾ÊµÓÃÐÂÐÍÉæ¼°Ò½ÁÆÓþßÁìÓò£¬¾ßÌåÉæ¼°Ò»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Öá£
±³¾°¼¼Êõ£º
Ŀǰ¹úÄÚÍâÓÃѪÇå×÷ÑùÆ·½øÐи÷ÖÖʵÑé¼ì²âÓë·ÖÎöʱ£¬¾ùÊDzÉÓþ²Âö³éѪ·ÖÀëѪÇåºó²ÅÄܽøÐи÷ÖÖʵÑé¼ì²â£¬ÓÉÓÚÕâÒ»´«Í³²ÉÑù·½·¨·±Ëö£¬²ÉѪÁ¿¶à£¬·ÖÀëѪÇåÓÃʱ³¤£¬²»¾¼Ã£¬ÓÈÆäÊǶÔ΢ѻ·ÕϰºÍÓ¤Ó×¶ù»¼ÕßµÄÈ¡Ñù¼«ÎªÀ§ÄÑ£¬²¢Ó°ÏìʵÑé½á¹ûµÄ׼ȷÐÔ¡£ÁíÍâÔÚ²ÉÑù¹ý³ÌÖÐʹÓÃÒ»´ÎÐÔ×¢ÉäÆ÷£¬Ò»µ©´¦Àí²»µ±»á¸ø»·¾³Ôì³ÉÎÛȾ£¬²»ÀûÓÚ»ù²ã¡¢Å©´å¡¢²¿¶ÓºÍÓ¤Ó×¶ùµÄ½¡¿µÆÕ²é¡£
ʵÓÃÐÂÐÍÄÚÈÝΪÁ˿˷þÏÖÓм¼ÊõÊÕ¼¯ÑªÇåµÄ²»×㣬±¾ÊµÓÃÐÂÐÍÖ¼ÔÚÌṩһÖÖ¿ÉÒÔ¿ìËÙ¡¢×¼È·¡¢·½±ãµÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Öá£ÎªÁËʵÏÖÉÏÊöÄ¿µÄ£¬±¾ÊµÓÃÐÂÐÍËù²ÉÓõļ¼Êõ·½°¸ÊÇÒ»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬰üÀ¨´øÆ¿¿ÚµÄÆ¿Ì壬ƿ¿ÚÉÏ×°ÓÐÆ¿×죬ƿ×ìµÄºó¶ËÓëÆ¿¿ÚÁ¬½Ó£¬²¢ÇÒÆ¿×ìµÄºó¶ËÉèÓÐÖ§¼Ü£¬Ö§¼ÜÉÏÉèÓи²¸ÇÆ¿¿ÚµÄ΢¿×ÂËĤ¡£Ò»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Öû¹°üÀ¨ÓÃÓÚÆð±£»¤×÷ÓÃµÄÆ¿¸Ç¡£ÏÂÃæ¶Ô±¾ÊµÓÃÐÂÐÍ×ö½øÒ»²½ÏêϸµÄ²ûÊö±¾ÊµÓÃÐÂÐÍÊǽ«Î¢¿×ÂËĤ²Ã³ÉÊʵ±´óС·ÅÈëÂËĤËÜÁÏÖ§¼ÜÖУ¬ÈÈѹ³ÉÐÍ£¬ÓëµÎƿƿÉíÒ»Æð¹¹³Éϸ°ûÂ˹ýµÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Öᣱ¾ÊµÓÃÐÂÐÍʹÓõÄ΢¿×ÂËĤµÄ¿×¾¶Îª3 ¦Ì m-5 ¦Ì m,¼ÈÄÜ×èֹϸ°ûÂ˹ý£¬ÓÖÄÜÈÃС·Ö×ÓÀàÎïÖÊ(È粡¶¾¡¢¿¹Ô¡¢¿¹ÌåµÈÎïÖÊ)ÉøÍ¸¹ýµÄ΢¿×ÂËĤ£¬Í¨¹ýÂËĤµÄ×÷ÓÃÀ´·ÖÀëѪϸ°û£¬ ¶øÊÕ¼¯ÑªÇå¡£±¾ÊµÓÃÐÂÐ͵ÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°ÖÃÖÆ±¸Ò»¶¨Á¿µÄ΢Á¿ÑªÇ壬¸ù¾ÝÆä±¶±È¹ØÏµºÍרÓÃÒ©ºÐ¶ÔHAV¡¢HIV¡¢Anti-HCV¡¢HBsAgµÈÔ±¶ÑªÇåÑùÆ·10·ÝµÄ±È½Ï²â¶¨£¬¾Í³¼ÆÑ§±È½Ï·ÖÎö¾ùP > 0. 05ÎÞÏÔÖø²îÒ죬Ïà·ûÂÊ´ï100%¡£¶Ô΢Á¿Ö¸ÑªÓÃÏÔ΢¾µ½øÐкìϸ°û¹Û²ì¼°Ó봫ͳ·½·¨ÊÕ¼¯ÑªÇå±È½ÏÏà·ûÂÊ´ï100%¡£(¾ßÌå¶Ô±ÈÊý¾Ý²Î¼ûʵʩÀý)±¾ÊµÓÃÐÂÐ͵ÄÓÅÊÆÔÚÓÚ±¾ÊµÓÃÐÂÐ͵ÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬽ṹ¼òµ¥¡¢²Ù×÷·½±ã׼ȷ¡¢Ð¯´øÈÝÒס¢Îª½ñºó΢Á¿¡¢³¬Î¢Á¿ÊµÑéÊÒ¼ì²â¼¼ÊõÌṩ¿ÉÐÐÒÀ¾Ý£¬ÍØÕ¹ÐµÄ˼·¡£
ͼ1ÊDZ¾ÊµÓÃÐÂÐ͵ÄʵʩÀýÖÐÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·×°ÖõĽṹʾÒâͼ£»Í¼2ÊÇʵʩÀýÖÐ΢¿×ÂËĤ½á¹¹Ê¾Òâͼ£»ÆäÖÐͼ2(a)ºÍͼ2(c)Ϊ²»Í¬³ß´çµÄ΢¿×ÂËĤÆÊÃæÍ¼£¬Í¼2(b)Ϊͼ2(a)µÄ΢¿×ÂËĤ²àÊÓͼ£¬Í¼2(d)Ϊͼ2(c)µÄ΢¿×ÂËĤ²àÊÓͼ¡£[0015]ͼ3ÊÇʵʩÀýÖÐÆ¿Ã±µÄ½á¹¹Ê¾Òâͼ£»Í¼ÖÐ1Ϊƿ×ì¡¢2Ϊ΢¿×ÂËĤ¡¢3ΪƿÌ壬4Ϊƿñ£¬Í¼Öи÷Êý×ֵĵ¥Î»ÎªºÁÃס£
¾ßÌåʵʩ·½Ê½
½áºÏ¸½Í¼¶Ô±¾ÊµÓÃÐÂÐ͵Äʵʩ·½Ê½×ö½øÒ»²½ËµÃ÷Èçͼ1Ëùʾ£¬Ò»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬰üÀ¨´øÆ¿¿ÚµÄÆ¿Ìå3£¬ÆäÌØÕ÷ÊÇ£¬Æ¿¿ÚÉÏ×°ÓÐÆ¿×ì1£¬Æ¿×ì1µÄºó¶ËÓëÆ¿¿ÚÁ¬½Ó£¬²¢ÇÒÆ¿×ì1µÄºó¶ËÉèÓÐÖ§¼Ü£¬Ö§¼ÜÉÏÉèÓи²¸ÇÆ¿¿ÚµÄ΢¿×ÂËĤ2¡£Î¢¿×ÂËĤ2µÄ½á¹¹Èçͼ2Ëùʾ£¬ÆäÖÐͼ2(a)ºÍͼ2(c)Ϊ²»Í¬³ß´çµÄ΢¿×ÂËĤÆÊÃæÍ¼£¬Í¼2(b)Ϊͼ2(a)µÄ΢¿×ÂËĤ²àÊÓͼ£¬Í¼2(d)Ϊͼ2(c)µÄ΢¿×ÂËĤ²àÊÓͼ¡£ÓÃÒ»´ÎÐÔÎÞ¾ú²ÉѪÕëÍ·È¡200 ¦Ì LѪÑù£¬ÓÃ200 ¦Ì LѪҺϡÊÍҺϡÊÍ£¬±¾ÊµÓÃÐÂÐ͵ÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·×°ÖùýÂËÊÕ¼¯µÃµ½Ô¼320 ¦Ì LµÄѪÇ壬½«ÊÕ¼¯ºóµÄ10·Ý¸ÃѪÇ壬 ·Ö±ðͨ¹ýÓ봫ͳ·½·¨ÊÕ¼¯ÑªÇåµÄÊ®·ÝÑùÆ·½øÐжԱÈʵÑ飬ÓÃÏÔ΢¾µ¹Û²ìºìϸ°ûºÍHAV¡¢HIV¡¢ Anti-HCV¡¢HbsAg(×ÔÖÆÎ¢Á¿Ò©ºÐºÍ³£¹æÒ©ºÐ)µÄ±È½Ï²â¶¨£¬Æä½á¹û¾Í³¼ÆÑ§±È½Ï·ÖÎö¾ùP > 0. 05£¬²îÒìÎÞÏÔÖøÒâÒ壬·ûºÏÂÊ´ï100%£¬½á¹û¼û±í1-5¡£±í1΢¿×ÂËĤÊÕ¼¯ÑªÇåÓ봫ͳ·½·¨ÊÕ¼¯ÑªÇå¹Û²ìRBC±È½Ï
ȨÀûÒªÇó1.Ò»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬰üÀ¨´øÆ¿¿ÚµÄÆ¿Ìå(3)£¬ÆäÌØÕ÷ÊÇ£¬Æ¿¿ÚÉÏ×°ÓÐÆ¿×ì(1)£¬Æ¿×ì(1)µÄºó¶ËÓëÆ¿¿ÚÁ¬½Ó£¬²¢ÇÒÆ¿×ì(1)µÄºó¶ËÉèÓÐÖ§¼Ü£¬Ö§¼ÜÉÏÉèÓи²¸ÇÆ¿¿ÚµÄ΢¿×ÂËĤO)¡£
2.¸ù¾ÝȨÀûÒªÇó1ËùÊöÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Öã¬ÆäÌØÕ÷ÊÇ£¬»¹°üÀ¨ÓÃÓÚÆð±£»¤×÷ÓÃµÄÆ¿¸ÇG)¡£
רÀûÕªÒª±¾ÊµÓÃÐÂÐÍÉæ¼°Ò½ÁÆÓþßÁìÓò£¬¾ßÌåÉæ¼°Ò»ÖÖÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬰üÀ¨´øÆ¿¿ÚµÄÆ¿Ìå(3)£¬Æ¿¿ÚÉÏ×°ÓÐÆ¿×ì(1)£¬Æ¿×ì(1)µÄºó¶ËÓëÆ¿¿ÚÁ¬½Ó£¬²¢ÇÒÆ¿×ì(1)µÄºó¶ËÉèÓÐÖ§¼Ü£¬Ö§¼ÜÉÏÉèÓи²¸ÇÆ¿¿ÚµÄ΢¿×ÂËĤ(2)¡£¸Ã×°Öû¹°üÀ¨ÓÃÓÚÆð±£»¤×÷ÓÃµÄÆ¿¸Ç(4)¡£±¾ÊµÓÃÐÂÐ͵ÄÓÃÓÚ¿ìËÙÊÕ¼¯Î¢Á¿ÑªÇåÑùÆ·µÄ×°Ö㬽ṹ¼òµ¥¡¢²Ù×÷·½±ã׼ȷ¡¢Ð¯´øÈÝÒס¢Îª½ñºó΢Á¿¡¢³¬Î¢Á¿ÊµÑéÊÒ¼ì²â¼¼ÊõÌṩ¿ÉÐÐÒÀ¾Ý£¬ÍØÕ¹ÐµÄ˼·¡£
Îĵµ±àºÅG01N1/38GK202057537SQ201120147608
¹«¿ªÈÕ2011Äê11ÔÂ30ÈÕ ÉêÇëÈÕÆÚ2011Äê5ÔÂ10ÈÕ ÓÅÏÈȨÈÕ2011Äê5ÔÂ10ÈÕ
·¢Ã÷ÕßÏÄÔ˳É, ³ÂÐÂÈð ÉêÇëÈË:ÏÄÔ˳É